Related Experiment Video
Updated: May 20, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from
Umang Shah1, Niyati Patel1, Mehul Patel1
1Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), CHARUSAT Campus, Changa, 388421, India.
Abstract:
Breast cancer is a global health concern, demanding innovative treatments. Targeting the Transforming Growth Factor-beta (TGF-β) signaling pathway, pivotal in breast cancer, is a promising approach. TGF-β inhibits proliferation via G1 phase cell cycle arrest, acting as a suppressor initially, but in later stages, it promotes progression by enhancing motility, invasiveness, and metastasis formation. This study explores naturally occurring flavonoids' interactions with TGF-β. Using molecular docking against the protein's crystal structure (PDB Id: 1PY5), Gossypin showed the highest docking score and underwent molecular dynamics simulation, revealing complex flexibility and explaining how flavonoids impede TGF-β signaling in breast cancer. ADMET predictions adhered to Lipinski's rule of Five. Insights into flavonoid-TGF-β binding offer a novel angle for breast cancer treatment. Flavonoids having a good docking score like gossypin, morin, luteolin and taxifolin shown potent cytotoxic effect on breast cancer cell line, MCF-7. Understanding these interactions could inspire flavonoid-based therapies targeting TGF-β to halt breast cancer growth. These findings pave the way for personalized, targeted breast cancer therapies, offering hope against this formidable disease.
Insights
Naturally occurring flavonoids show potential in targeting the Transforming Growth Factor-beta (TGF-β) signaling pathway for breast cancer treatment. Gossypin demonstrated significant interaction, offering a new avenue for developing flavonoid-based therapies against cancer progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Breast cancer is a significant global health challenge requiring novel therapeutic strategies.
- The Transforming Growth Factor-beta (TGF-β) signaling pathway plays a dual role in breast cancer, initially suppressing and later promoting tumor progression, metastasis, and invasiveness.
- Targeting the TGF-β pathway presents a promising therapeutic avenue for breast cancer treatment.
Purpose of the Study:
- To investigate the interactions between naturally occurring flavonoids and the TGF-β signaling pathway.
- To identify specific flavonoids that can effectively impede TGF-β signaling in breast cancer.
- To explore the potential of these flavonoids as novel therapeutic agents for breast cancer.
Main Methods:
- Molecular docking simulations were performed using the crystal structure of TGF-β (PDB Id: 1PY5).
- Molecular dynamics simulations were conducted to analyze the flexibility and binding interactions of top-scoring flavonoids.
- Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictions were evaluated using Lipinski's rule of Five.
Main Results:
- Gossypin exhibited the highest docking score, indicating a strong interaction with TGF-β.
- Molecular dynamics simulations elucidated the mechanism by which flavonoids impede TGF-β signaling.
- Flavonoids with favorable docking scores, including gossypin, morin, luteolin, and taxifolin, demonstrated potent cytotoxic effects on the MCF-7 breast cancer cell line.
- ADMET predictions suggested favorable pharmacokinetic properties for the studied flavonoids.
Conclusions:
- Naturally occurring flavonoids can effectively interact with and inhibit the TGF-β signaling pathway.
- Gossypin and other identified flavonoids show promise as lead compounds for developing new breast cancer therapies.
- These findings support the development of targeted, flavonoid-based therapies to combat breast cancer progression and metastasis.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
Cancer Prevention
Some...
TGF - β Signaling Pathway